{{Rsnum
|rsid=1465073
|Gene=PFDN5
|Chromosome=12
|position=53299619
|Orientation=minus
|GMAF=0.3999
|Gene_s=C12orf10,PFDN5
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 11.1 | 44.4 | 44.4
| HCB | 31.1 | 53.3 | 15.6
| JPT | 25.0 | 52.3 | 22.7
| YRI | 9.5 | 30.2 | 60.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 31.1 | 53.3 | 15.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=20377893
|Title=Promoter polymorphism -119C/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1
|OA=1
}}

{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}